Paolo De Sanctis1, Sheryl Green2, Isabelle Germano3. 1. Humanitas School of Medicine, Milan, Italy. 2. Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 3. Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA. isabelle.germano@mountsinai.org.
Abstract
BACKGROUND: Communicating hydrocephalus (cHCP) after radiosurgery (RS) for vestibular schwannomas (VS) has been reported. Many hypothetical mechanisms for this pathology have been proposed without consensus. The aim of this study is to determine if the platform used to treat the disease, Gamma Knife (GK) versus linear accelerator (LINAC)-based RS, makes a difference in outcome. METHODS: We conducted a meta-analysis of databases PubMed and Cochrane to identify all articles for the period January 2000-August 2018 with the following inclusion criteria: (1) VS treated with single fraction SRS (2) > 10 patients (3) original reports only (4) hydrocephalus reported as complication (5) human study. RESULTS: A total of 7039 and 988 VS patients reported in 35 and 10 papers were treated with GK or LINAC RS, respectively. Demographic baseline characteristics not reported in aggregate did not differ between the two groups. The incidence of cHCP was 3% [95% CI 2-4] and 2% [95% CI 1-3] for GK and LINAC RS patients, respectively. Surgical CSF diversion was performed in 88% and 68% of patients evaluated for cHPC in the GK and LINAC group, respectively. Follow-up range was 30-150 and 29-92 months for GK and LINAC, respectively. CONCLUSIONS: The incidence of cHCP following RS for VS is very low in both GK and LINAC treated patients, albeit not identical. The higher reported surgical intervention rate for VS patients treated with GK RS might be multi-factorial, including longer follow-up in the GK group.
BACKGROUND:Communicating hydrocephalus (cHCP) after radiosurgery (RS) for vestibular schwannomas (VS) has been reported. Many hypothetical mechanisms for this pathology have been proposed without consensus. The aim of this study is to determine if the platform used to treat the disease, Gamma Knife (GK) versus linear accelerator (LINAC)-based RS, makes a difference in outcome. METHODS: We conducted a meta-analysis of databases PubMed and Cochrane to identify all articles for the period January 2000-August 2018 with the following inclusion criteria: (1) VS treated with single fraction SRS (2) > 10 patients (3) original reports only (4) hydrocephalus reported as complication (5) human study. RESULTS: A total of 7039 and 988 VSpatients reported in 35 and 10 papers were treated with GK or LINAC RS, respectively. Demographic baseline characteristics not reported in aggregate did not differ between the two groups. The incidence of cHCP was 3% [95% CI 2-4] and 2% [95% CI 1-3] for GK and LINAC RS patients, respectively. Surgical CSF diversion was performed in 88% and 68% of patients evaluated for cHPC in the GK and LINAC group, respectively. Follow-up range was 30-150 and 29-92 months for GK and LINAC, respectively. CONCLUSIONS: The incidence of cHCP following RS for VS is very low in both GK and LINAC treated patients, albeit not identical. The higher reported surgical intervention rate for VSpatients treated with GK RS might be multi-factorial, including longer follow-up in the GK group.
Entities:
Keywords:
Gamma knife; Hydrocephalus; Linear accelerator (LINAC); Radiosurgery; Vestibular schwannoma
Authors: Rick van de Langenberg; Patrick E J Hanssens; Jeroen B Verheul; Jacobus J van Overbeeke; Patty J Nelemans; Amy J C Dohmen; Bert J de Bondt; Robert J Stokroos Journal: J Neurosurg Date: 2011-08-12 Impact factor: 5.115
Authors: H Benghiat; G Heyes; P Nightingale; A Hartley; M Tiffany; D Spooner; J I Geh; G Cruickshank; R M Irving; P Sanghera Journal: Clin Oncol (R Coll Radiol) Date: 2014-03-11 Impact factor: 4.126
Authors: Benjamin J Arthurs; Wayne T Lamoreaux; Alexander R Mackay; John J Demakas; Neil A Giddings; Robert K Fairbanks; Barton S Cooke; Ameer L Elaimy; Ben Peressini; Christopher M Lee Journal: Am J Clin Oncol Date: 2011-06 Impact factor: 2.339
Authors: Qasim Al Hinai; Anthony Zeitouni; Denis Sirhan; David Sinclair; Denis Melancon; John Richardson; Richard Leblanc Journal: J Neurol Surg B Skull Base Date: 2013-02-07
Authors: J G Rowe; M W R Radatz; L Walton; A Hampshire; S Seaman; A A Kemeny Journal: J Neurol Neurosurg Psychiatry Date: 2003-11 Impact factor: 10.154
Authors: Seunghoon Lee; Seong-Wook Seo; Juyoung Hwang; Ho Jun Seol; Do-Hyun Nam; Jung-Il Lee; Doo-Sik Kong Journal: Cancer Med Date: 2016-11-23 Impact factor: 4.452
Authors: Dong Won Shin; Sang Woo Song; SangJoon Chong; Young Hoon Kim; Young Hyun Cho; Seok Ho Hong; Jeong Hoon Kim Journal: J Clin Neurol Date: 2021-07 Impact factor: 3.077